Latest News about MRNA
Recent news which mentions MRNA
Why Is Moderna (MRNA) Stock Down 5% Today?
February 17, 2023
From InvestorPlace
Pfizer/BioNTech Get Ready For London Court Battle With Moderna Over COVID-19 Vaccine Patents
February 17, 2023
From Benzinga
Bad news for the ‘pessimistic bulls’. Here’s 10 reasons why a U.S recession won’t happen.
February 17, 2023
From MarketWatch
Moderna, Cognex, Stem And Other Big Stocks Moving Lower In Friday's Pre-Market Session
February 17, 2023
From Benzinga
Nasdaq, S&P 500 Futures Indicate Weak Opening For Wall Street: Benefit Of Lowering Recession Risk Comes With Sticky Inflation Threat, Says Economist
February 17, 2023
From Benzinga
Tesla, DraftKings, DoorDash, Moderna, Stem: Why These Five Stocks Are Drawing Investors' Attention Today
February 16, 2023
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 16, 2023
From Benzinga
A Bull Market Is Coming. To Prepare, Take Warren Buffett's Advice.
February 16, 2023
From Motley Fool
Moderna’s COVID vaccine will remain free for all Americans in coup for Bernie Sanders
February 16, 2023
From MarketWatch
7 Hot Healthcare Stocks With the Potential to Outperform
February 15, 2023
From InvestorPlace
These 20 companies are bucking a mostly negative earnings trend. Here’s what that means for their stocks.
February 14, 2023
From MarketWatch
Is This the Telltale Sign to Sell Novavax Stock?
February 14, 2023
From Motley Fool
Candy? Flowers? These Top Stocks Offer You Something Even Sweeter
February 14, 2023
From Motley Fool
5 Value Stocks In The Healthcare Sector
February 13, 2023
From Benzinga
Fox, MGM Resorts And 3 Other Stocks Insiders Are Selling
February 13, 2023
From Benzinga
Here are five companies to pick if Goldman Sachs is right about the stock market being flat in 2023
February 13, 2023
From MarketWatch
These Cheap Growth Stocks Could Supercharge Your Portfolio
February 12, 2023
From Motley Fool
From Benzinga
Is Novavax Stock a Buy With the New Normal for COVID?
February 10, 2023
From Motley Fool
Analyst Upgrades Personalis; Says Biopharma Is Strong, Cash Burn Is Down
February 06, 2023
From Benzinga
1 Company Bucks the Office REIT Trend With Higher Rents and Earnings
February 06, 2023
From Motley Fool
Danaher Shows Interest In Acquiring Catalent Valued At Significant Premium: Report
February 06, 2023
From Benzinga
EXCLUSIVE: Top 10 Most Searched Tickers On Benzinga Pro In January: Where Do SPY, Tesla, Apple And Ford Rank?
February 05, 2023
From Benzinga
3 No-Brainer Growth Stocks to Buy in 2023
February 03, 2023
From Motley Fool
Why Personalis Shares Are Trading Higher Today
February 03, 2023
From Benzinga
The 7 Most Undervalued Biotech Stocks to Buy in February 2023
February 02, 2023
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.